Esophageal tumor length is independently associated with long- Term survival

Cancer

Volumn 115, Issue 3, 2009, Pages 508-516

  Yendamuri, Sai ^a   Swisher, Stephen G ^a   Correa, Arlene M ^a   Hofstetter, Wayne ^a   Ajani, Jaffer A ^a   Francis, Ashleigh ^a   Maru, Dipen ^a   Mehran, Reza J ^a   Rice, David C ^a   Roth, Jack A ^a   Walsh, Garrett L ^a   Vaporciyan, Ara A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Esophageal cancer; Esophageal cancer survival; Long term survival; Tumor size

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS;

EID: 60049100491     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24062     Document Type: Article

References (13)

1. DeMeester SR. Adenocarcinoma of the esophagus and cardial a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12-30.
2. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11:235-256.
3. Rusch VW. Should the esophageal cancer staging system be revised? J Thorac Cardiovasc Surg. 2003;125:992-993.
4. Rice TW, Blackstone EH, Rybicki LA, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg. 2003;125:1103-1113.
5. Griffiths EA, Brummel Z, Gorthi G, et al. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol. 2006;93: 258-267.
6. Thompson WM. Esophageal cancer. Int J Radiat Oncol Biol Phys. 1983;9:1533-1565.
7. Tachibana M, Kinugasa S, Dhar DK, et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol. 1999;72:88-93.
8. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 2002;95:1434-1443.
9. Bollschweiler E,Baldus SE,Schroder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94:355-363.
10. Shinkai M, Niwa Y, Arisawa T, et al. Evaluation of prognosis of squamous cell carcinoma of the oesophagus by endoscopic ultrasonography. Gut. 2000;47:120-125.
11. Swisher SG, Hofstetter W, Wu II, et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg. 2005;241:810-817; discussion 817-820.
12. Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132:1374-1381.
13. Zhu SC, Li R, Wang YX, et al. Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer - possible incorporation into clinical TNM staging system. World J Gastroenterol. 2005;11:3823-3829.